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Introduction
============

Ischemic heart disease (IHD) is a major cause of morbidity and mortality worldwide \[[@REF1]-[@REF3]\]. Males are more commonly affected by this condition than females. Atherosclerotic coronary artery disease (CAD) causing myocardial ischemia may manifest itself either as acute myocardial infarction (AMI), unstable angina, or effort angina. Among these, AMI is the most predominant life-threatening disease usually encountered in emergency hospital admissions. The mortality rate for AMI has decreased by about 30% over the last two decades, but it still remains high, especially in underdeveloped countries. The cardiovascular comorbidities associated with AMI are on the rise in Pakistan where 18% of the adult population suffers from hypertension, tobacco addiction, and obesity.

Left ventricular thrombus (LVT) is a blood clot that forms in the left ventricle of heart due to stasis of blood. LVT leading to cerebrovascular accidents is a potentially catastrophic complication following anterior ST-segment elevation myocardial infarction (STEMI) \[[@REF4]\]. Although anticoagulation is often prescribed for this, data regarding the appropriate drug, duration, risks, and effect on echocardiographic indices of thrombus are lacking. Moreover, given the difficulty in obtaining adequate anticoagulation with warfarin, it is possible that short-term treatment with a more predictable agent would be more effective \[[@REF5],[@REF6]\]. Acute thromboembolic events due to LVT formation, particularly in patients with reduced ejection fraction (EF), remain a risk for patients surviving anterior STEMI. The reported incidence of LVT formation and subsequent embolization varies based on the timing of the echocardiographic examination and the diagnosis, anticoagulation, and reperfusion strategies utilized in managing the initial presentation. However, it is estimated to range from 0 to as high as 86% \[[@REF7],[@REF8]\]. A study conducted by Zia et al. has reported LVT formation in 15.4% of patients with anterior wall acute myocardial infarction (AWMI). While LVT was found in 5.4% of the patients thrombolyzed with streptokinase, it was present in 30.4% of those who were not thrombolyzed \[[@REF9]\].

The purpose of our study was to evaluate the frequency of LVT formation in thrombolyzed and non-thrombolyzed patients with AMI to ascertain the current magnitude of the problem in the local population. We believe that the results of this study will help clinicians to anticipate LVT among the targeted population and treat them accordingly. We also feel that the study provides useful baseline information on this topic and highlights the importance of thrombolytic therapy in AMI patients, which will contribute to improving clinical outcomes in these patients. Finally, we think our findings will improve the quality of life of the patients and will also help reduce hospital costs, which will be beneficial for national health economies.

Materials and methods
=====================

This descriptive study was conducted at the Department of Cardiology, Chaudhry Pervaiz Elahi Institute of Cardiology in Multan, Pakistan. We conducted the study after obtaining approval from the institute\'s Ethical Review Committee. A total of 281 patients of either gender aged between 30-65 years with AWMI (both thrombolyzed and non-thrombolyzed) were included in the study based on consecutive sampling over a period of one year. Informed consent was taken from the patients/attendants of patients after explaining the objectives of this study, ensuring the confidentiality of the information provided, and providing assurance that the patients were in no danger due to participating in this research. Once they were enrolled in the study, all the relevant baseline investigations were performed. A detailed history was taken and examinations were done; serial ECG and echocardiography were performed till discharge from the hospital on the third day of hospitalization to record the final outcome of the study, i.e., LVT formation. All the data was recorded on a predesigned proforma.

Statistical analysis

All the data was entered and analyzed using IBM SPSS Statistics for Windows, Version 20.0 (IBM, Armonk, NY). Descriptive statistics were applied to calculate the mean and standard deviation for the age of the patients and the duration of symptoms. Frequencies and percentages were compiled for categorical variables. The frequency of LVT was compared between thrombolyzed and non-thrombolyzed patients by applying the chi-square test at a level of significance of 0.05. Effect modifiers like age and diabetes were controlled by preparing stratified charts. The post-stratification chi-square test was applied to see its effect on outcomes. A p-value of ≤0.05 was considered to be statistically significant.

Results
=======

Our study comprised a total of 281 patients who met the inclusion criteria. Of the 281 patients, 184 (65.5%) were male and 97 (34.5%) were female. The mean age of the patients was 55.54 ± 7.26 years (range: 40-65 years). Most of the patients (204, 72.6%) were more than 50 years of age. Of the 281 patients, 106 (37.7%) belonged to rural areas and 175 (62.3%) belonged to urban areas. Diabetes was present in 87 (31%) subjects, hypertension in 130 (46.3%), and 65 (23.1%) had a history of smoking. The mean duration of symptoms was 7.25 ± 3.82 hours, and 151 (53.7%) patients had a duration of symptoms for more than six hours. Family history was positive in 106 (37.7%), while thrombolytic therapy was given for 194 (69.0%) of our study cases. LVT formation was noted in 65 (23.1%) cases, of which 11 (16.9%) were thrombolyzed patients and 54 (83.1%) non-thrombolyzed. The characteristics of the study population are presented in Table [1](#TAB1){ref-type="table"}.

###### Characteristics of the study population

  ------------------------------------------
  Characteristic
  Gender
  Male
  Female
  Age group
  ≤50 years
  \>50 years
  Residence
  Rural
  Urban
  Diabetes mellitus
  Present
  Absent
  Hypertension
  Present
  Absent
  Smoking
  Present
  Absent
  Duration of symptoms
  ≤6 hours
  \>6 hours
  Family history of Ischemic heart disease
  Present
  Absent
  Thrombolytic therapy
  Given
  Not given
  Left ventricular thrombus formation
  Present
  Absent
  ------------------------------------------

Our results showed a significant association of LVT formation with age (p = 0.039), hypertension (p: \<0.001), symptoms duration (p: \<0.01), family history of IHD, and thrombolytic therapy (p: \<0.001), as presented in Table [2](#TAB2){ref-type="table"}.

###### Association of left ventricular thrombus formation with clinical features and comorbidities

Chi-square test was applied; p-value of ≤0.05 considered statistically significant

\*P-value significant

\*\*P-value not significant

  ------------------------------------------ ----------- ------------
  Characteristic                             N (%)       P-value
                                             Present     Absent
  Gender                                                  
  Male                                       44 (67.7)   140 (64.8)
  Female                                     21 (32.3)   76 (35.2)
  Age group                                               
  ≤50 years                                  11 (16.9)   66 (30.6)
  \>50 years                                 54 (83.1)   150 (69.4)
  Residence                                               
  Rural                                      21 (32.3)   85 (39.4)
  Urban                                      44 (67.7)   131 (60.6)
  Diabetes mellitus                                       
  Present                                    22 (33.8)   65 (30)
  Absent                                     43 (66.2)   151 (70)
  Hypertension                                            
  Present                                    43 (66.1)   87 (40.3)
  Absent                                     22 (33.9)   129 (59.7)
  Smoking                                                 
  Present                                    11 (16.9)   54 (25)
  Absent                                     54 (83.1)   162 (75)
  Duration of symptoms                                    
  ≤6 hours                                   11 (16.9)   119 (55.1)
  \>6 hours                                  54 (83.1)   97 (44.9)
  Family history of Ischemic heart disease                
  Present                                    10 (15.4)   96 (44.4)
  Absent                                     55 (84.6)   120 (55.6)
  Thrombolytic therapy                                    
  Given                                      11 (16.9)   183 (84.7)
  Not given                                  54 (83.1)   33 (15.3)
  ------------------------------------------ ----------- ------------

Discussion
==========

LVT is a known sequel of AMI owing to stasis of blood over damaged heart muscles, which can lead to systemic embolization resulting in a stroke. Early reperfusion is the most effective treatment modality in such circumstances while therapeutic anticoagulation is useful in preventing the risk of thrombosis and embolization \[[@REF10]\].

We found LVT formation in 65 (23.1%) of our study subjects, of which 11 (16.9%) were thrombolyzed patients while 54 (83.1%) were non-thrombolyzed. Our findings vary slightly from those of other loco-regional studies. A study conducted by Zia et al. has reported an LVT incidence of 15.4% in patients with AWMI. While LVT was found in 5.4% of the patients thrombolyzed with streptokinase, it was present in 30.4% of those who were not thrombolyzed \[[@REF9]\]. Another study from Norway by Solheim et al. has reported similar results, showing a high prevalence of LVT in non-thrombolyzed patients \[[@REF11]\].

We found a male predominance (65.9%) in our studied patient population. The male predominance with respect to AMI has been well documented in the literature. Loco-regional literature has shown male gender predominance ranging from 65% to as high as 80% in a few studies \[[@REF9],[@REF12],[@REF13]\]. Our study results were consistent with these findings.

The mean duration of symptoms was 7.25 ± 3.82 hours, and 151 (53.7%) patients had a duration of symptoms for more than six hours. Family history was positive in 106 (37.7%), while thrombolytic therapy was given for 194 (69.0%) of our study cases. The mean age of the patients was 55.54 ± 7.26 years (range: 40-65 years). The mean age of the male patients was noted to be 55.51 ± 8.22 years, while that of female patients was 55.60 ± 4.98 years (p=0.924). Most of the patients (204, 72.6%) were more than 50 years of age. The mean age in other regional studies was reported to range from 53 to 55 years \[[@REF9],[@REF12],[@REF13]\], which was consistent with our data.

Our study has a few limitations. Firstly, this was a single-institution study; however, the institute has a high influx of patients from both the rural and urban areas, and hence the patient population was quite representative of the country\'s general population. Secondly, we did not engage in a long-term follow-up of the patients to evaluate other long-term complications of AMI in the studied population.

Conclusions
===========

In our study, we found a high frequency of LVT formation among patients with AWMI who have not undergone thrombolytic therapy. We also observed a significant association of LVT with advanced age, hypertension, and other comorbidities. Early presentation to the hospital and thrombolysis reduce the risk of developing LVT, which in turn can bring down morbidity and mortality in such patients.
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